VANACOF by is a Otc medication manufactured, distributed, or labeled by GM Pharmaceuticals, INC. Drug facts, warnings, and ingredients follow.
Do not exceed recommended dosage.
If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product
Do not exceed recommended dosage.
adults and children 12 years of age and over: | 2 teaspoonfuls every 6 hours, not to exceed 8 teaspoonfuls in 24 hours. |
children 6 to under 12 years of age: | 1 teaspoonful every 6 hours, not to exceed 4 teaspoonfuls in 24 hours. |
children under 6 years of age: | consult a doctor. |
NDC: 58809-999-01
VanaCof®
Each 5 mL (1 TEASPOONFUL) CONTAINS:
Chlophedianol Hydrochloride
….. 12.5 mg
Dexchlorpheniramine Maleate
….. 1 mg
Pseudoephedrine Hydrochloride
….. 30mg
VANACOF
chlophedianol hydrochloride, dexchlorpheniramine maleate, and pseudoephedrine hydrochloride liquid |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - GM Pharmaceuticals, INC (793000860) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VANACOF 77310107 3565619 Live/Registered |
GM Pharmaceuticals, Inc. 2007-10-22 |